# US 2004/0071733 A1 · Baculovirus vector vaccine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0071733 A1
- Document ID: US20040071733A1
- Status: Published application
- Kind: A1
- Application number: 10/470,888
- Filed: 2003-10-20
- Published: 2004-04-15
- Earliest claimed: 2001-02-05
- Inventors: Hiroshi Takaku; Yosuke Suzuki
- Web page: https://patentgrep.com/patent/US20040071733A1

## CPC

- C12N 15/86: Viral vectors
- A61K 39/12: Viral antigens
- A61K 39/145: Orthomyxoviridae, e.g. influenza virus
- A61P 31/12: Antivirals
- A61P 31/16: for influenza or rhinoviruses
- C07K 14/005: from viruses
- A61K 2039/5256: {expressing foreign proteins}
- A61K 2039/543: {intranasal}
- C12N 2710/14143: viral genome or elements thereof as genetic vector
- C12N 2760/16122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2760/16134: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

It is intended to provide virus vector vaccine preparations containing as the main component a virus vector with the use of a virus showing no pathogenicity on humans and being free from a risk of the re-acquisition of pathogenicity. Namely, vaccine preparations containing as the main component a baculovirus having a gene encoding an antigen integrated thereinto are provided.

## Claims

### Claim 1

A vaccine preparation containing as a main component a non-human host virus wherein a gene coding for an antigen has been incorporated.

### Claim 2 (depends on 1)

The vaccine preparation according to claim 1 wherein the non-human host virus is a baculovirus.

### Claim 3 (depends on 1, 2)

The vaccine preparation according to claim 1 or 2 wherein the antigen is a virus membrane protein antigen.

### Claim 4 (depends on 3)

The vaccine preparation according to claim 3 wherein the virus membrane protein antigen is an influenza HA antigen.

### Claim 5 (depends on 1, 2, 3, 4)

The vaccine preparation according to any one of claims 1 to 4 wherein the preparation further contains an adjuvant and/or a pharmaceutically acceptable carrier.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The vaccine preparation according to any one of claims 1 to 5 wherein the preparation is nasally administered.
